ArticleCase reports in ophthalmology

Fulminant Marginal Keratitis Induced by Atezolizumab, a Programmed Death Ligand 1 Inhibitor for Lung Cancer.

Masashi Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.